Hollsteen
← Microchip

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $564M · 10-Q 0000827054-15-000134 filed Aug 6, 2015Cash and equivalents · Q2 FY2016: $539M · 10-Q 0000827054-15-000218 filed Nov 9, 2015Cash and equivalents · Q3 FY2016: $331M · 10-Q 0000827054-16-000265 filed Feb 5, 2016Cash and equivalents · Q4 FY2016: $2.1B · 10-K 0001628280-18-006982 filed May 18, 2018Cash and equivalents · Q1 FY2017: $601M · 10-Q 0000827054-16-000385 filed Aug 9, 2016Cash and equivalents · Q2 FY2017: $490M · 10-Q 0000827054-16-000472 filed Nov 8, 2016Cash and equivalents · Q3 FY2017: $664M · 10-Q 0000827054-17-000018 filed Feb 8, 2017Cash and equivalents · Q4 FY2017: $909M · 10-K 0001628280-18-006982 filed May 18, 2018Cash and equivalents · Q1 FY2018: $773M · 10-Q 0000827054-17-000132 filed Aug 4, 2017Cash and equivalents · Q2 FY2018: $826M · 10-Q 0000827054-17-000203 filed Nov 7, 2017Cash and equivalents · Q3 FY2018: $672M · 10-Q 0000827054-18-000021 filed Feb 7, 2018Cash and equivalents · Q4 FY2018: $901M · 10-K 0001628280-18-006982 filed May 18, 2018Cash and equivalents · Q1 FY2019: $635M · 10-Q 0000827054-18-000143 filed Aug 9, 2018Cash and equivalents · Q2 FY2019: $460M · 10-Q 0000827054-18-000249 filed Nov 7, 2018Cash and equivalents · Q3 FY2019: $432M · 10-Q 0000827054-19-000018 filed Feb 6, 2019Cash and equivalents · Q4 FY2019: $429M · 10-K 0000827054-19-000143 filed May 30, 2019Cash and equivalents · Q1 FY2020: $434M · 10-Q 0000827054-19-000197 filed Aug 7, 2019Cash and equivalents · Q2 FY2020: $402M · 10-Q 0000827054-19-000288 filed Nov 6, 2019Cash and equivalents · Q3 FY2020: $397M · 10-Q 0000827054-20-000029 filed Feb 4, 2020Cash and equivalents · Q4 FY2020: $401M · 10-K 0000827054-20-000119 filed May 22, 2020Cash and equivalents · Q1 FY2021: $378M · 10-Q 0000827054-20-000186 filed Aug 4, 2020Cash and equivalents · Q2 FY2021: $368M · 10-Q 0000827054-20-000278 filed Nov 5, 2020Cash and equivalents · Q3 FY2021: $371M · 10-Q 0000827054-21-000025 filed Feb 4, 2021Cash and equivalents · Q4 FY2021: $280M · 10-K 0000827054-21-000106 filed May 18, 2021Cash and equivalents · Q1 FY2022: $278M · 10-Q 0000827054-21-000187 filed Aug 3, 2021Cash and equivalents · Q2 FY2022: $253M · 10-Q 0000827054-21-000280 filed Nov 4, 2021Cash and equivalents · Q3 FY2022: $314M · 10-Q 0000827054-22-000025 filed Feb 3, 2022Cash and equivalents · Q4 FY2022: $317M · 10-K 0000827054-22-000094 filed May 20, 2022Cash and equivalents · Q1 FY2023: $377M · 10-Q 0000827054-22-000148 filed Aug 2, 2022Cash and equivalents · Q2 FY2023: $305M · 10-Q 0000827054-22-000193 filed Nov 3, 2022Cash and equivalents · Q3 FY2023: $289M · 10-Q 0000827054-23-000020 filed Feb 2, 2023Cash and equivalents · Q4 FY2023: $234M · 10-K 0000827054-23-000080 filed May 25, 2023Cash and equivalents · Q1 FY2024: $271M · 10-Q 0000827054-23-000132 filed Aug 3, 2023Cash and equivalents · Q2 FY2024: $257M · 10-Q 0000827054-23-000185 filed Nov 2, 2023Cash and equivalents · Q3 FY2024: $281M · 10-Q 0000827054-24-000024 filed Feb 1, 2024Cash and equivalents · Q4 FY2024: $320M · 10-K 0000827054-24-000098 filed May 23, 2024Cash and equivalents · Q1 FY2025: $315M · 10-Q 0000827054-24-000139 filed Aug 1, 2024Cash and equivalents · Q2 FY2025: $286M · 10-Q 0000827054-24-000206 filed Nov 5, 2024Cash and equivalents · Q3 FY2025: $586M · 10-Q 0000827054-25-000019 filed Feb 6, 2025Cash and equivalents · Q4 FY2025: $772M · 10-K 0000827054-25-000077 filed May 23, 2025Cash and equivalents · Q1 FY2026: $566M · 10-Q 0000827054-25-000133 filed Aug 7, 2025Cash and equivalents · Q2 FY2026: $237M · 10-Q 0000827054-25-000183 filed Nov 6, 2025Cash and equivalents · Q3 FY2026: $251M · 10-Q 0000827054-26-000009 filed Feb 5, 2026Cash and equivalents · Q4 FY2026: $240M · 10-K 0000827054-26-000016 filed May 21, 2026Cash and equivalents · Q1 FY2027: $272M · 10-Q 0000827054-26-000038 filed Aug 6, 20262725642,093Q1 FY2016Q1 FY2027Q3 FY2021
$MCash and equivalents · Q2 FY2025: $286M · 10-Q 0000827054-24-000206 filed Nov 5, 2024Cash and equivalents · Q3 FY2025: $586M · 10-Q 0000827054-25-000019 filed Feb 6, 2025Cash and equivalents · Q4 FY2025: $772M · 10-K 0000827054-25-000077 filed May 23, 2025Cash and equivalents · Q1 FY2026: $566M · 10-Q 0000827054-25-000133 filed Aug 7, 2025Cash and equivalents · Q2 FY2026: $237M · 10-Q 0000827054-25-000183 filed Nov 6, 2025Cash and equivalents · Q3 FY2026: $251M · 10-Q 0000827054-26-000009 filed Feb 5, 2026Cash and equivalents · Q4 FY2026: $240M · 10-K 0000827054-26-000016 filed May 21, 2026Cash and equivalents · Q1 FY2027: $272M · 10-Q 0000827054-26-000038 filed Aug 6, 2026272286772Q2 FY2025Q1 FY2027Q2 FY2026
Q1 FY2027
272$M
All values (45)
PeriodValue ($M)Status
Q1 FY2027272reported
Q4 FY2026240reported
Q3 FY2026251reported
Q2 FY2026237reported
Q1 FY2026566reported
Q4 FY2025772reported
Q3 FY2025586reported
Q2 FY2025286reported
Q1 FY2025315reported
Q4 FY2024320reported
Q3 FY2024281reported
Q2 FY2024257reported
Q1 FY2024271reported
Q4 FY2023234reported
Q3 FY2023289reported
Q2 FY2023305reported
Q1 FY2023377reported
Q4 FY2022317reported
Q3 FY2022314reported
Q2 FY2022253reported
Q1 FY2022278reported
Q4 FY2021280reported
Q3 FY2021371reported
Q2 FY2021368reported
Q1 FY2021378reported
Q4 FY2020401reported
Q3 FY2020397reported
Q2 FY2020402reported
Q1 FY2020434reported
Q4 FY2019429reported
Q3 FY2019432reported
Q2 FY2019460reported
Q1 FY2019635reported
Q4 FY2018901reported
Q3 FY2018672reported
Q2 FY2018826reported
Q1 FY2018773reported
Q4 FY2017909reported
Q3 FY2017664reported
Q2 FY2017490reported
Q1 FY2017601reported
Q4 FY20162,093reported
Q3 FY2016331reported
Q2 FY2016539reported
Q1 FY2016564reported

CSV with all sources · Technical ID: cash

More metrics for Microchip

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$272M
Period
Q1 FY2027, ended Jun 30, 2026 · as of Jun 30, 2026 (balance as of date, not a sum)
Source
10-Q, filed Aug 6, 2026 · 0000827054-26-000038
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$272MAug 6, 202610-Q 0000827054-26-000038reported · confidence 1. · current